Sequantrix GmbH

Founding year

2023

Sector

Life Sciences / Biotechnology

Description

Sequantrix^TM was created by leading pioneers in fibrosis research, clinical care and computational science to address the large, unmet medical need for anti-fibrotic therapies.
Our approach starts with the systematic discovery and validation of novel, anti-fibrotic targets by leveraging some of the world’s largest human multi-modal, single-cell datasets
in the field of fibrotic diseases.
Our aim is to develop anti-fibrotic drug candidates up to the clinical proof of concept. We have identified several novel anti-fibrotic targets of high biological relevance and will swiftly
move to drug candidate development.